Literature DB >> 22694239

Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention.

Jaclyn M White1, Matthew J Mimiaga, Douglas S Krakower, Kenneth H Mayer.   

Abstract

The Center for the AIDS Programme of Research in South Africa (CAPRISA) 004 and Pre-exposure Prophylaxis Initiative (iPrEx) studies demonstrated that topical or oral chemoprophylaxis could decrease HIV transmission. Yet to have an appreciable public health impact, physicians will need to be educated about these new HIV prevention modalities. Massachusetts physicians were recruited via e-mail to complete an online survey of their knowledge and use of HIV prevention interventions. Data were collected before (July-December, 2010) (n=178) and after (December, 2010-April, 2011) (n=115) the release of iPrEx data. Over the two time intervals, knowledge of oral PrEP significantly increased (79% to 92%, p<0.01), whereas knowledge about topical microbicides was already high (89% pre-iPrEx). Post-iPrEx, specialists were more knowledgeable about oral PrEP (p<0.01) and topical microbicides (p<0.001) than generalists. The majority of the respondents would prefer to prescribe topical microbicides (75%) than oral PrEP (25%; p<0.001), primarily because they perceived fewer side effects (95%). Respondents indicated that PrEP should be available if it were a highly effective, daily pill; however, ongoing concerns included: potential drug resistance (93%), decreased funds for other forms of HIV prevention (88%), medication side effects (83%), and limited data regarding PrEP's clinical efficacy (75%). Participants indicated that formal CDC guidelines would have the greatest impact on their willingness to prescribe PrEP (96%). Among Massachusetts physicians sampled, chemoprophylaxis knowledge was high, but current experience was limited. Although topical gel was preferred, responses suggest a willingness to adapt practices pending additional efficacy data and further guidance from normative bodies. Educational programs aimed at incorporating antiretroviral chemoprophylaxis into physicians' HIV prevention practices are warranted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22694239      PMCID: PMC3432573          DOI: 10.1089/apc.2012.0030

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  26 in total

1.  Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-01-28       Impact factor: 17.586

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Preexposure prophylaxis for HIV: unproven promise and potential pitfalls.

Authors:  Albert Y Liu; Robert M Grant; Susan P Buchbinder
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

Review 4.  Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.

Authors:  Gavin M Myers; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2011-02       Impact factor: 5.078

5.  A US policy perspective on oral preexposure prophylaxis for HIV.

Authors:  Arleen A Leibowitz; Karen Byrnes Parker; Mary Jane Rotheram-Borus
Journal:  Am J Public Health       Date:  2011-04-14       Impact factor: 9.308

6.  Discussion of sexual risk behavior in HIV care is infrequent and appears ineffectual: a mixed methods study.

Authors:  M Barton Laws; Ylisabyth S Bradshaw; Steven A Safren; Mary Catherine Beach; Yoojin Lee; William Rogers; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-05

7.  Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.

Authors:  Matthew J Mimiaga; Patricia Case; Carey V Johnson; Steven A Safren; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

8.  Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center.

Authors:  Kenneth H Mayer; Matthew J Mimiaga; Daniel Cohen; Chris Grasso; Ronn Bill; Rodney Van Derwarker; Alvan Fisher
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-01       Impact factor: 3.731

9.  HIV medical care provider practices for reducing high-risk sexual behavior: results of a qualitative study.

Authors:  Mari-Lynn Drainoni; Debra Dekker; Elizabeth Lee-Hood; Ulrike Boehmer; Michael Relf
Journal:  AIDS Patient Care STDS       Date:  2009-05       Impact factor: 5.078

10.  Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities.

Authors:  Susan C Kim; Stephen Becker; Carl Dieffenbach; Blair S Hanewall; Catherine Hankins; Ying-Ru Lo; John W Mellors; Kevin O'Reilly; Lynn Paxton; Jason S Roffenbender; Mitchell Warren; Peter Piot; Mark R Dybul
Journal:  J Int AIDS Soc       Date:  2010-07-12       Impact factor: 5.396

View more
  57 in total

Review 1.  How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".

Authors:  Sarah K Calabrese; Kristen Underhill
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

2.  Clinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in Delivery.

Authors:  Susanne Doblecki-Lewis; Stephanie Cohen; Albert Liu
Journal:  Curr Treat Options Infect Dis       Date:  2015-06

3.  Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.

Authors:  Jill Blumenthal; Sonia Jain; Douglas Krakower; Xiaoying Sun; Jason Young; Kenneth Mayer; Richard Haubrich
Journal:  AIDS Behav       Date:  2015-05

Review 4.  Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care.

Authors:  Andrew Silapaswan; Douglas Krakower; Kenneth H Mayer
Journal:  J Gen Intern Med       Date:  2016-10-19       Impact factor: 5.128

5.  Intimacy motivations and pre-exposure prophylaxis (PrEP) adoption intentions among HIV-negative men who have sex with men (MSM) in romantic relationships.

Authors:  Kristi E Gamarel; Sarit A Golub
Journal:  Ann Behav Med       Date:  2015-04

6.  Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.

Authors:  Christina J Sun; Kirsten M Anderson; David Bangsberg; Kim Toevs; Dayna Morrison; Caitlin Wells; Pete Clark; Christina Nicolaidis
Journal:  J Gen Intern Med       Date:  2019-02-04       Impact factor: 5.128

Review 7.  Engaging healthcare providers to implement HIV pre-exposure prophylaxis.

Authors:  Douglas Krakower; Kenneth H Mayer
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

8.  Healthcare Provider Contact and Pre-exposure Prophylaxis in Baltimore Men Who Have Sex With Men.

Authors:  Julia R G Raifman; Colin Flynn; Danielle German
Journal:  Am J Prev Med       Date:  2016-09-20       Impact factor: 5.043

9.  Attitudes toward HIV pre-exposure prophylaxis among men who have sex with men in western China.

Authors:  Yan Zhang; Bin Peng; Ying She; Hao Liang; Hong-Bin Peng; Han-Zhu Qian; Sten H Vermund; Xiao-Ni Zhong; Ailong Huang
Journal:  AIDS Patient Care STDS       Date:  2013-02-20       Impact factor: 5.078

10.  HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.

Authors:  Douglas Krakower; Norma Ware; Jennifer A Mitty; Kevin Maloney; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.